# Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery

> **NCT03460509** · PHASE4 · UNKNOWN · sponsor: **The Hospital of Vestfold** · enrollment: 144 (estimated)

## Conditions studied

- Postoperative Residual Curarization
- Neuromuscular Block

## Interventions

- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT03460509
- **Lead sponsor:** The Hospital of Vestfold
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460509, "Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03460509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*